240 related articles for article (PubMed ID: 17537299)
1. [Predictive value of soluble vascular endothelial growth factor receptor 1 for preeclampsia in second-trimester].
Chen Q; Zhao Y; Zou L; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):161-4. PubMed ID: 17537299
[TBL] [Abstract][Full Text] [Related]
2. [Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester].
Ye YH; Liu L; Zhan Y; Peng W
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):433-5. PubMed ID: 17083803
[TBL] [Abstract][Full Text] [Related]
3. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
[TBL] [Abstract][Full Text] [Related]
4. [Alteration and potential role of soluble fms-like tyrosine kinase receptor 1 in preeclampsia].
Li Y; Li DH; Yao YQ; Min BH; Zhang CL; Hou XH; Huang L; Zhao HX
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):581-4. PubMed ID: 16202309
[TBL] [Abstract][Full Text] [Related]
5. [The predictive value of plasma fibronectin concentration on fetal growth retardation and preeclampsia at earlier stage of the third trimester].
Xiong G; Wang Z; Yu Q
Zhonghua Fu Chan Ke Za Zhi; 2001 Dec; 36(12):734-7. PubMed ID: 16136894
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum sFlt-1/Ang-2 ratio in women with preeclampsia.
Hirokoshi K; Maeshima Y; Kobayashi K; Matsuura E; Sugiyama H; Yamasaki Y; Masuyama H; Hiramatsu Y; Makino H
Nephron Clin Pract; 2007; 106(1):c43-50. PubMed ID: 17409768
[TBL] [Abstract][Full Text] [Related]
7. [Expression and significance of soluble fms-like tyrosine kinase 1 in preeclampsia placenta].
Ye YH; Liu L; Zhan Y; Peng W
Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):521-4. PubMed ID: 17083834
[TBL] [Abstract][Full Text] [Related]
8. Plasma markers of angiogenesis in pregnancy induced hypertension.
Nadar SK; Karalis I; Al Yemeni E; Blann AD; Lip GY
Thromb Haemost; 2005 Nov; 94(5):1071-6. PubMed ID: 16363251
[TBL] [Abstract][Full Text] [Related]
9. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
[TBL] [Abstract][Full Text] [Related]
10. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia.
Verlohren S; Galindo A; Schlembach D; Zeisler H; Herraiz I; Moertl MG; Pape J; Dudenhausen JW; Denk B; Stepan H
Am J Obstet Gynecol; 2010 Feb; 202(2):161.e1-161.e11. PubMed ID: 19850276
[TBL] [Abstract][Full Text] [Related]
11. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.
Buhimschi CS; Norwitz ER; Funai E; Richman S; Guller S; Lockwood CJ; Buhimschi IA
Am J Obstet Gynecol; 2005 Mar; 192(3):734-41. PubMed ID: 15746665
[TBL] [Abstract][Full Text] [Related]
12. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
[TBL] [Abstract][Full Text] [Related]
13. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award.
Chaiworapongsa T; Romero R; Espinoza J; Bujold E; Mee Kim Y; Gonçalves LF; Gomez R; Edwin S
Am J Obstet Gynecol; 2004 Jun; 190(6):1541-7; discussion 1547-50. PubMed ID: 15284729
[TBL] [Abstract][Full Text] [Related]
14. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia.
Chaiworapongsa T; Romero R; Kim YM; Kim GJ; Kim MR; Espinoza J; Bujold E; Gonçalves L; Gomez R; Edwin S; Mazor M
J Matern Fetal Neonatal Med; 2005 Jan; 17(1):3-18. PubMed ID: 15804781
[TBL] [Abstract][Full Text] [Related]
15. [The role of plasma placental isoferritin in pathogenesis of preeclampsia and its predictive value for preeclampsia].
Wang Z; Zhu Y
Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):209-11. PubMed ID: 11783362
[TBL] [Abstract][Full Text] [Related]
16. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop.
McKeeman GC; Ardill JE; Caldwell CM; Hunter AJ; McClure N
Am J Obstet Gynecol; 2004 Oct; 191(4):1240-6. PubMed ID: 15507947
[TBL] [Abstract][Full Text] [Related]
17. Adhesion molecules changes at 20 gestation weeks in pregnancies complicated by preeclampsia.
Chavarría ME; Lara-González L; García-Paleta Y; Vital-Reyes VS; Reyes A
Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):157-64. PubMed ID: 17706337
[TBL] [Abstract][Full Text] [Related]
18. Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF.
Krysiak O; Bretschneider A; Zhong E; Webb J; Hopp H; Verlohren S; Fuhr N; Lanowska M; Nonnenmacher A; Vetter R; Jankowski J; Paul M; Schönfelder G
Circ Res; 2005 Dec; 97(12):1253-61. PubMed ID: 16269656
[TBL] [Abstract][Full Text] [Related]
19. Maternal plasma fibronectin and advanced oxidative protein products for the prediction of preeclampsia in high risk pregnancies: a prospective cohort study.
Dane C; Buyukasik H; Dane B; Yayla M
Fetal Diagn Ther; 2009; 26(4):189-94. PubMed ID: 19923789
[TBL] [Abstract][Full Text] [Related]
20. Maternal erythrocyte malondialdehyde level in preeclampsia prediction: a longitudinal study.
Basbug M; Demir I; Serin IS; Ozcelik B; Saraymen R; Narin F; Tayyar M
J Perinat Med; 2003; 31(6):469-74. PubMed ID: 14711102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
